Merck & Co. on Thursday reported a drop in second-quarter profit, hurt by a tax charge and the withdrawal last year of its Vioxx arthritis drug.
*For more on this story,
read the full Reuters article.
Merck & Co. on Thursday reported a drop in second-quarter profit, hurt by a tax charge and the withdrawal last year of its Vioxx arthritis drug.
*For more on this story,
read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99